Irene Norstedt is Head of Unit for the Innovative and Personalised Medicine Unit it in the Health Research Directorate in DG Research and Innovation. This Unit is focusing on personalised medicine and supports research in –omics, diagnostics, rare diseases and various aspects of personalised medicine including piloting personalised medicine in health care. She has been working with European life sciences research aspects at the European Commission since 1996. During 2015 she was also Acting Executive Director for the Innovative Medicines Initiative (IMI), a public private partnership between the EC and the Pharmaceutical industry. Previous responsibilities at the EC have primarily focussed on Small and Medium size Enterprises and industry aspects of biotechnology and health research at European level. Before starting her job in Brussels she worked for Biacore AB in Uppsala, Sweden. There she had several positions and she has also worked as Assistant Technical Attaché at the Swedish Embassy in London.